Related Experiment Video
Updated: Jul 10, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
Development of liver disease despite mannose treatment in two patients with CDG-Ib
K Mention1, F Lacaille, V Valayannopoulos
1Department of Paediatrics and Reference Centre for Metabolism, AP-HP, Necker Enfants Malades Hospital, 149 Rue de Sèvres, Paris Cedex, France.
Abstract:
We report here the 6- and 2-year follow-up of two patients diagnosed at 2 months of age with CDG-Ib who were treated with mannose, with digestive symptoms, liver involvement and hyperinsulinemic hypoglycaemia. Both developed liver fibrosis while general condition improved and other symptoms disappeared.
Related Concept Videos
Cirrhosis II: Pathophysiology
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Chronic Pancreatitis II: Pathophysiology
Chronic Pancreatitis II: Collaborative Care
Assessment:
Cirrhosis I: Introduction
